On Thursday, Shares of Western Digital Corp (NASDAQ:WDC), lost -0.79% to $77.90.
Seeking to bring outstanding medical care and wellness coaching directly to the workplace, St. Joseph Hoag Health and Western Digital together have -created a ground-breaking wellness center in Western Digital’s world headquarters in Irvine, Calif. The center is slated to open this month.
The 4,600-square-foot holistic, multispecialty DRIVE Wellness Center is designed to serve more than 1,800 employees. One of the first-of-its-kind for a large tech firm in the region, the center will be an integrated multispecialty clinic offering primary and preventative care, physical therapy, acupuncture, chiropractic and behavioral health services within the workplace. St. Joseph Hoag Health will manage the center, providing all clinical and operations expertise.
Western Digital Corporation, through its auxiliaries, develops, manufactures, and sells data storage solutions that enable consumers, businesses, governments, and other organizations to create, manage, experience, and preserve digital content. It provides hard disk drives (HDDs) and solid-state drives for desktop and notebook personal computers (PCs), and performance enterprise and capacity enterprise markets.
Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), declined -2.94% to $9.26, during its last trading session.
Keryx Biopharmaceuticals, declared that two national insurance providers have added Auryxiato their Medicare Part D formularies. Auryxia is the first and only absorbable, iron-based phosphate binder for the treatment of elevated serum phosphorus levels in people with chronic kidney disease on dialysis. Together, these new formularies will enhance unrestricted access to Auryxia, across Medicare Part D and commercial insurance providers, to about 65 percent of people in the U.S. presently taking phosphate binders.
“The inclusion of Auryxia on these major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” said Greg Madison, Chief Executive Officer of Keryx Biopharmaceuticals. “We are progressing nicely towards our aim of broad, unrestricted access to about 80 percent of phosphate binder prescriptions, across both Medicare Part D and commercial insurance providers, within 12 months post-approval. Looking ahead, we are focused on ongoing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
At the end of Thursday’s trade, Shares of JDS Uniphase Corp (NASDAQ:JDSU), gained 1.34% to $11.34.
JDSU, will declare its fiscal fourth quarter and year-end 2015 financial results for the period ended June 27, 2015, on Tuesday, August 11, 2015, after close of market.
JDSU anticipates to complete the spinoff of its Communications and Commercial Optical Product business segment (“CCOP”) as Lumentum Holdings Inc. on Saturday, August 1, 2015, at which time JDSU will be renamed Viavi Solutions Inc.
JDS Uniphase Corporation provides network and service enablement solutions and optical products worldwide. The company’s Network and Service Enablement segment offers network and service enablement solutions that enable the design, development, deployment, and maintenance of communication equipment and networks. This segments product portfolio comprises of test tools, platforms, microprobes, software, and services for wireless and fixed networks.
Finally, Coeur Mining Inc (NYSE:CDE), ended its last trade with -7.93% loss, and closed at $3.83.
Coeur Mining, declared proven and probable reserves at the recently-attained Wharf gold mine in South Dakota of about 781,000 gold ounces. This represents a 39% enhance from the last stated reserve estimate at Wharf by Goldcorp from year-end 2013 of 560,000 ounces. The addition of these new reserves at Wharf results in a 35% enhance in Coeur’s total gold reserves to 3.0 million ounces.
Mitchell J. Krebs, Coeur’s President and Chief Executive Officer, said, “Given the importance of Wharf to our Company, we felt it was necessary to take the time to complete a more informed resource model based on pre-existing data to improve our mine planning and ability to execute according to plan. We were optimistic that this effort would result in additional reserves based on the mine’s history of positive reconciliations between the reserve model and production. The results have surpassed our expectations by adding three years of predictable mine life, making Wharf a key producing asset for Coeur for at least the next decade. We are optimistic that exploration efforts now underway around the existing open pit will further add to Wharf’s reserves.”
Coeur Mining, Inc., through its auxiliaries, engages in the ownership, operation, exploration, and development of silver and gold mining properties primarily in the United States, Mexico, Bolivia, Argentina, Australia, Ecuador, Chile, and New Zealand.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
